Group One Trading’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-961
| Closed | -$188K | – | 7772 |
|
|
2026
Q1 | $188K | Sell |
961
-3,005
| -76% | -$584K | ﹤0.01% | 4155 |
|
|
2025
Q4 | $688K | Buy |
+3,966
| New | +$722K | ﹤0.01% | 3217 |
|
|
2025
Q3 | – | Sell |
-4,413
| Closed | -$783K | – | 8535 |
|
|
2025
Q2 | $793K | Buy |
4,413
+3,689
| +510% | +$641K | ﹤0.01% | 2980 |
|
|
2025
Q1 | $123K | Buy |
+724
| New | +$119K | ﹤0.01% | 4433 |
|
|
2024
Q4 | – | Sell |
-2,171
| Closed | -$338K | – | 7410 |
|
|
2024
Q3 | $337K | Buy |
2,171
+694
| +47% | +$104K | ﹤0.01% | 3161 |
|
|
2024
Q2 | $202K | Buy |
+1,477
| New | +$202K | ﹤0.01% | 3373 |
|
|
2024
Q1 | – | Sell |
-4,039
| Closed | -$524K | – | 7211 |
|
|
2023
Q4 | $557K | Buy |
4,039
+970
| +32% | +$128K | ﹤0.01% | 2980 |
|
|
2023
Q3 | $374K | Buy |
+3,069
| New | +$409K | ﹤0.01% | 3209 |
|
|
2023
Q2 | – | Sell |
-2,366
| Closed | -$326K | – | 7746 |
|
|
2023
Q1 | $335K | Buy |
+2,366
| New | +$339K | ﹤0.01% | 3155 |
|
|
2021
Q3 | – | Sell |
-19,254
| Closed | -$2.82M | – | 8275 |
|
|
2021
Q2 | $2.54M | Sell |
19,254
-239
| -1% | -$31.3K | ﹤0.01% | 2391 |
|
|
2021
Q1 | $2.5M | Buy |
+19,493
| New | +$2.4M | ﹤0.01% | 2218 |
|
|
2020
Q2 | – | Sell |
-16,894
| Closed | -$1.79M | – | 5851 |
|
|
2020
Q1 | $1.36M | Buy |
+16,894
| New | +$1.75M | 0.01% | 1296 |
|
|
2019
Q3 | – | Sell |
-2,332
| Closed | -$239K | – | 5216 |
|
|
2019
Q2 | $237K | Buy |
+2,332
| New | +$224K | ﹤0.01% | 2722 |
|
|
2019
Q1 | – | Sell |
-16,405
| Closed | -$1.42M | – | 4908 |
|
|
2018
Q4 | $1.37M | Buy |
16,405
+12,468
| +317% | +$1.17M | 0.01% | 1281 |
|
|
2018
Q3 | $425K | Buy |
+3,937
| New | +$432K | ﹤0.01% | 2417 |
|
|
2018
Q2 | – | Sell |
-8,300
| Closed | -$865K | – | 5164 |
|
|
2018
Q1 | $832K | Buy |
+8,300
| New | +$850K | 0.01% | 1654 |
|
|
2017
Q4 | – | Sell |
-600
| Closed | -$56.9K | – | 4904 |
|
|
2017
Q3 | $56K | Buy |
600
+500
| +500% | +$53.1K | ﹤0.01% | 3572 |
|
|
2017
Q2 | $11K | Buy |
+100
| New | +$10.6K | ﹤0.01% | 4172 |
|
|
2016
Q3 | – | Sell |
-7,304
| Closed | -$613K | – | 4597 |
|
|
2016
Q2 | $595K | Buy |
7,304
+3,400
| +87% | +$259K | 0.01% | 1610 |
|
|
2016
Q1 | $279K | Buy |
+3,904
| New | +$262K | ﹤0.01% | 2104 |
|
|
2015
Q4 | – | Sell |
-3,399
| Closed | -$229K | – | 4797 |
|
|
2015
Q3 | $209K | Buy |
+3,399
| New | +$238K | ﹤0.01% | 2469 |
|
|
2014
Q4 | – | Sell |
-218
| Closed | -$13.8K | – | 4952 |
|
|
2014
Q3 | $13K | Buy |
+218
| New | +$13.4K | ﹤0.01% | 4332 |
|
|
2014
Q2 | – | Sell |
-415
| Closed | -$24.3K | – | 5220 |
|
|
2014
Q1 | $24K | Buy |
+415
| New | +$22.2K | ﹤0.01% | 4123 |
|
Other funds holding DGX
EIG
Group One Trading's DGX Position: Q2 2026 in Review
Group One Trading sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 961 shares — an estimated $188K sold.
Group One Trading first reported a position in DGX in Q1 2014 and held it in 23 quarters. The position peaked at $2.54M in Q2 2021. 1,110 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Group One Trading reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
- Group One Trading sold 961 Quest Diagnostics shares in Q2 2026, an estimated $188K.
- Group One Trading first reported a position in Quest Diagnostics in Q1 2014 and held it in 23 quarters.
- Group One Trading's Quest Diagnostics position peaked at $2.54M in Q2 2021.
- 1,110 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.